{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:32:45Z","timestamp":1773948765055,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1097\/md.0000000000008408","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T22:01:19Z","timestamp":1509573679000},"page":"e8408","source":"Crossref","is-referenced-by-count":22,"title":["Treatment of triple-negative breast cancer with Chinese herbal medicine"],"prefix":"10.1097","volume":"96","author":[{"given":"Hui","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guowang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-23-20210226","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/annonc\/mds187","article-title":"Triple-negative breast cancer: epidemiological considerations and recommendations","volume":"23","author":"Boyle","year":"2012","journal-title":"Ann Oncol"},{"key":"R2-23-20210226","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.2165\/11538150-000000000-00000","article-title":"Triple-negative breast cancer: epidemiology and management options","volume":"70","author":"Dawood","year":"2010","journal-title":"Drugs"},{"key":"R3-23-20210226","first-page":"417","article-title":"Biological characteristics and treatment of three negative breast cancer","volume":"25","author":"Yunbin","year":"2012","journal-title":"Clin Res China"},{"key":"R4-23-20210226","first-page":"R97","article-title":"A clinical relevant gene signature in triple negative and basal-like breast cancer","volume":"13","author":"Rody","year":"2011","journal-title":"Medicine"},{"key":"R5-23-20210226","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J Clin Invest"},{"key":"R6-23-20210226","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","article-title":"Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100000 women in 123 randomised trials.","volume":"379","year":"2012","journal-title":"Lancet"},{"key":"R7-23-20210226","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"R8-23-20210226","first-page":"6","article-title":"Advantages of traditional Chinese medicine in the treatment of cancer","volume":"20","author":"Cihui","year":"2013","journal-title":"Chinese J Inform TCM"},{"key":"R9-23-20210226","first-page":"108","article-title":"Systematic evaluation on the synergism and toxicity reduction of TCM combined with chemotherapy in solid tumors","volume":"16","author":"Jun","year":"2010","journal-title":"Guiding Journal of Traditional Chinese Medicine and Pharmacy"},{"key":"R10-23-20210226","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5582\/bst.2015.01019","article-title":"The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer","volume":"9","author":"Qi","year":"2015","journal-title":"BioSci Trends"},{"key":"R11-23-20210226","doi-asserted-by":"crossref","first-page":"e60338","DOI":"10.1371\/journal.pone.0060338","article-title":"Traditional Chinese medicine in cancer care: a review of controlled clinical studies published in Chinese","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"R12-23-20210226","first-page":"737","article-title":"The experience in the treatment of triple-negative breast cancer of Yu Rencun","volume":"54","author":"Qing","year":"2013","journal-title":"Journal of traditional Chinese medicine"},{"key":"R13-23-20210226","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response critetia of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"R14-23-20210226","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"R15-23-20210226","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1081\/CNV-200055960","article-title":"Management of cancer-related fatigue","volume":"23","author":"Morrow","year":"2005","journal-title":"Cancer Invest"},{"key":"R16-23-20210226","first-page":"1371","article-title":"Measurement of fatigue in people with cancer","volume":"28","author":"Wu","year":"2001","journal-title":"Oncol Nurs Forum"},{"key":"R17-23-20210226","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"R18-23-20210226","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.22381","article-title":"Prognostic markers in triple-negative breast cancer","volume":"109","author":"Rakha","year":"2007","journal-title":"Cancer"},{"key":"R19-23-20210226","first-page":"1045","article-title":"Clinical features and prognostic factors of three patients with 356 negative breast cancer","volume":"37","author":"Li","year":"2010","journal-title":"Clinical oncology in China"},{"key":"R20-23-20210226","first-page":"2735","article-title":"Antitumor effects of traditional Chinese medicine targeting the cellular apoptotic pathway","volume":"9","author":"Xu","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"R21-23-20210226","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.2005.03.6392","article-title":"Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials","volume":"24","author":"McCulloch","year":"2006","journal-title":"J Clin Oncol"},{"key":"R22-23-20210226","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.biocel.2014.05.021","article-title":"Use of herbal medicines and natural products: an alternative approach to overcoming the apoptotic resistance of pancreatic cancer","volume":"53","author":"Li","year":"2014","journal-title":"Int J Biochem C ell Biol"},{"key":"R23-23-20210226","first-page":"16","article-title":"Clinical study of Tribulus Bushen Mixture in treatment of triple-negative breast cancer after surgery","volume":"32","author":"Yuanzhong","year":"2010","journal-title":"Hubei Journal of Traditional Chinese Medicine"},{"key":"R24-23-20210226","first-page":"266","article-title":"Ethics and evidence-based medicine in clinical trial research","volume":"5","author":"Tingqian","year":"2005","journal-title":"Chinese journal of evidence-based medicine"},{"key":"R26-23-20210226","first-page":"1","article-title":"Evidence based medicine and clinical research","volume":"1","author":"Yilong","year":"2001","journal-title":"The Journal of Evidence-Based Medicine"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:38:00Z","timestamp":1620959880000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201711030-00023"}},"subtitle":["A prospective cohort study protocol"],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":25,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008408","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}